bpc-157 evidence human studies safety – No Proof Required! | Office for Science and Society bpc-157 human clinical trials evidence

PMID: 10977918

Results: Thirty-seven studies met inclusion criteria (observational studies (n = 32), qualitative (n = 4) and RCT (n = 1))

Had my 2nd dose on Monday

As posited by Qichun Zhang et al., the administration of BBR prior to the onset of treatment led to the activation of endogenous neuroprotective mechanisms associated with the sphingosine-1-phosphate (S1P)/HIF-1 pathway, thereby contributing to the protection of neuronal cells from the deleterious effects of hypoxia/ischemia (Zhang et al., 2016a)

A 20 l mix, containing 8 l of cDNA sample, 10 l of SYBR Green PCR Master Mix (Thermo Fisher Scientific), and 2 l of 10 mM forward primer and reverse primer mixture was used to performed Quantitative RT-PCR with a StepOne Plus Real-time PCR system (Applied Biosystems, Foster City, CA, United States)